|Videos|March 3, 2021
Dr. Thomas Powles explains standard treatment for metastatic urothelial cancer
Author(s)Urology Times staff
Treatment following progression on chemotherapy and an immune checkpoint inhibitor remains an unmet medical need.
Advertisement
Thomas Powles, MBBS, MRCP, MD, director, Barts Cancer Institute, discusses standard treatment for patients with metastatic urothelial cancer in the frontline setting and beyond.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Practical guide to female pelvic organ–sparing radical cystectomy
2
FDA grants 510(k) clearance to Break Wave lithotripsy device for kidney stones
3
Pearls & Perspectives: Navigating Evidence Gaps and Innovation in OAB Care, With Ariana Smith, MD
4
CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction
5